verapamil has been researched along with Carditis in 15 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of the calcium channel blocking agent, verapamil, were studied in a murine model of viral myocarditis." | 7.68 | Verapamil ameliorates the clinical and pathological course of murine myocarditis. ( Butany, J; Dong, R; Liu, P; Sole, MJ; Wee, L, 1992) |
| "The effect of verapamil (Ver) on CVB3 murine myocarditis was investigated." | 7.68 | Effect of verapamil on acute coxsackievirus B3 murine myocarditis. ( Cai, QX; Chen, HZ; Guo, Q; Jin, PY; Xu, Y; Yang, JH; Yang, YZ; Zhao, WZ; Zhou, YC, 1992) |
| "We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients." | 7.67 | Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984) |
| "The effects of the calcium channel blocking agent, verapamil, were studied in a murine model of viral myocarditis." | 3.68 | Verapamil ameliorates the clinical and pathological course of murine myocarditis. ( Butany, J; Dong, R; Liu, P; Sole, MJ; Wee, L, 1992) |
| "The effect of verapamil (Ver) on CVB3 murine myocarditis was investigated." | 3.68 | Effect of verapamil on acute coxsackievirus B3 murine myocarditis. ( Cai, QX; Chen, HZ; Guo, Q; Jin, PY; Xu, Y; Yang, JH; Yang, YZ; Zhao, WZ; Zhou, YC, 1992) |
| "We compared the effects of verapamil to high dose procainamide on the rate of inducible and spontaneously occurring ventricular tachycardia (VT) in 10 patients." | 3.67 | Verapamil in ventricular tachycardia. ( Gotsman, MS; Hasin, Y; Kriwisky, M, 1984) |
| "A four-month-old infant with myocarditis and supraventricular tachycardia was given intravenous verapamil (0." | 3.67 | An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. ( Berens, RJ; Garland, JS; Losek, JD; Wilson, AD, 1985) |
| "These findings, consistent with a dilated cardiomyopathy, were ameliorated in the early but not in the late treatment group, demonstrating that late treatment with verapamil is ineffective in reversing the development of chagasic cardiomyopathy in chronically infected mice." | 1.32 | Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. ( Chandra, M; De Souza, AP; Factor, SM; Huang, H; Jelicks, LA; Morris, SA; Shirani, J; Shtutin, V; Tanowitz, HB; Weiss, LM; Wittner, M, 2004) |
| "In the patients with a left bundle branch block morphology of VT (7 cases), four showed findings compatible with an arrhythmogenic right ventricular dysplasia or a right ventricular cardiomyopathy." | 1.27 | Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. ( Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Souza, AP | 1 |
| Tanowitz, HB | 1 |
| Chandra, M | 1 |
| Shtutin, V | 1 |
| Weiss, LM | 1 |
| Morris, SA | 1 |
| Factor, SM | 1 |
| Huang, H | 1 |
| Wittner, M | 1 |
| Shirani, J | 1 |
| Jelicks, LA | 1 |
| Hasin, Y | 2 |
| Kriwisky, M | 1 |
| Gotsman, MS | 1 |
| Fixler, R | 1 |
| Shimoni, Y | 1 |
| Hassin, D | 1 |
| Admon, D | 1 |
| Raz, S | 1 |
| Yarom, R | 1 |
| Prattichizzo, FA | 1 |
| Simonetti, I | 1 |
| Galetta, F | 1 |
| Rodrigues, LE | 1 |
| Pinto, G | 1 |
| Pinto, R | 1 |
| Machado, AE | 1 |
| Strubelt, O | 1 |
| Hoffmann, A | 1 |
| Siegers, CP | 1 |
| Sierra-Callejas, JL | 1 |
| Dong, R | 1 |
| Liu, P | 1 |
| Wee, L | 1 |
| Butany, J | 1 |
| Sole, MJ | 1 |
| Xu, Y | 1 |
| Yang, YZ | 1 |
| Chen, HZ | 1 |
| Jin, PY | 1 |
| Guo, Q | 1 |
| Zhao, WZ | 1 |
| Yang, JH | 1 |
| Cai, QX | 1 |
| Zhou, YC | 1 |
| Garland, JS | 1 |
| Berens, RJ | 1 |
| Losek, JD | 1 |
| Wilson, AD | 1 |
| Morgera, T | 1 |
| Salvi, A | 1 |
| Alberti, E | 1 |
| Silvestri, F | 1 |
| Camerini, F | 1 |
| Arsov, D | 1 |
| Serafimova, E | 1 |
| Osugi, S | 1 |
| Reckless, JP | 1 |
| Gilchrist, WS | 1 |
| Apitz, J | 1 |
| Gaissmaier, U | 1 |
| Bender, F | 1 |
| Reploh, HD | 1 |
15 other studies available for verapamil and Carditis
| Article | Year |
|---|---|
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection.
Topics: Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Chagas Cardiomyopathy; Chagas Disease; Dis | 2004 |
Verapamil in ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Dose-Response Relationship, D | 1984 |
Physiological changes induced in cardiac myocytes by cytotoxic lymphocytes: an autoimmune model.
Topics: Action Potentials; Animals; Autoimmune Diseases; Cell Transplantation; Cells, Cultured; Cytotoxicity | 1994 |
[Carditis associated with Mycoplasma pneumoniae infection. Clinical aspects and therapeutic problems].
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dose- | 1997 |
[Stabilizing action of verapamil "in vivo" upon the membrane of heart lysosomes (author's transl)].
Topics: Animals; Cell Membrane; Drug Evaluation; Guinea Pigs; Lysosomes; Myocarditis; Myocardium; Oxygen Con | 1977 |
On the pathogenesis of cardiac necroses induced by theophylline and caffeine.
Topics: Animals; Blood Pressure; Caffeine; Calcium; Gallopamil; Heart; Heart Rate; Isoproterenol; Male; Myoc | 1976 |
Verapamil ameliorates the clinical and pathological course of murine myocarditis.
Topics: Animals; Cardiomyopathy, Dilated; Encephalomyocarditis virus; Enterovirus Infections; Male; Mice; Mi | 1992 |
Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
Topics: Acute Disease; Animals; Coxsackievirus Infections; Enterovirus B, Human; Male; Mice; Mice, Inbred BA | 1992 |
An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil.
Topics: Humans; Infant; Male; Myocarditis; Shock; Tachycardia, Supraventricular; Verapamil | 1985 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; E | 1985 |
[Verapamil for regulation of cardiac rhythm disorders. Experience with our own patients].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Circulation; Cardiac Complexes, Pre | 1970 |
[Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Coronary Disea | 1971 |
An antidysrhythmic agent.
Topics: Humans; Injections, Intravenous; Male; Middle Aged; Myocarditis; Tachycardia, Paroxysmal; Verapamil | 1971 |
[Death after intravenous application of isoptin].
Topics: Anti-Arrhythmia Agents; Child; Endocardial Fibroelastosis; Humans; Injections, Intravenous; Male; My | 1971 |
[Management of ventricular tachycardias using Isoptin].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hyperkalemia; Inject | 1968 |